贝里穆马布
免疫学
转录组
医学
先天免疫系统
IRF7
系统性红斑狼疮
疾病
红斑狼疮
免疫系统
基因
生物
内科学
抗体
B细胞激活因子
基因表达
遗传学
B细胞
作者
Georgia-Savina Moysidou,Panagiotis Garantziotis,George Sentis,Dimitra Nikoleri,Nikolaos Malissovas,Myrto Nikoloudaki,Evgenia Stergioti,Styliani Polia,Nikolaos Paschalidis,Anastasia Filia,Maria Grigoriou,Dionysis Nikolopoulos,Noemin Kapsala,Spyridon Katechis,Antonis Fanouriakis,George Βertsias,Dimitrios T. Boumpas
标识
DOI:10.1136/ard-2024-226051
摘要
Belimumab is a putative disease-modifying agent in systemic lupus erythematosus (SLE), yet the molecular underpinnings of its effects and the ability to predict early clinical response remain unexplored. To address these, we undertook a longitudinal, in-depth blood transcriptome study.
科研通智能强力驱动
Strongly Powered by AbleSci AI